Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3

Peptides

Volumn 29, Issue 1, 2008, Pages 1-6

  Maisetta, Giuseppantonio ^a   Di Luca, Mariagrazia ^a   Esin, Semih ^a   Florio, Walter ^a   Brancatisano, Franca Lisa ^a   Bottai, Daria ^a   Campa, Mario ^a   Batoni, Giovanna ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Antimicrobial peptides; Defensins; Human beta defensin 3; Inhibition; Serum

Indexed keywords

BETA DEFENSIN 3; CALCIUM CHLORIDE; CATION; HUMAN ALBUMIN; PLASMA PROTEIN; PROTEINASE INHIBITOR; SODIUM CHLORIDE; TRYPSIN;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DILUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SERUM; STAPHYLOCOCCUS AUREUS; WESTERN BLOTTING;

ACINETOBACTER BAUMANNII; AMINO ACID CHLOROMETHYL KETONES; APROTININ; BENZAMIDINES; BETA-DEFENSINS; HUMANS; LACTIC ACID; MICROBIAL SENSITIVITY TESTS; PROTEASE INHIBITORS; SALTS; SERUM ALBUMIN; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

ACINETOBACTER BAUMANNII; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 37249076371     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.10.013     Document Type: Article

References (25)

1. Aparicio J.R., Viedma J.A., Aparisi L., Navarro S., Martinez J., and Perez-Mateo M. Usefulness of carbohydrate-deficient transferrin and trypsin activity in the diagnosis of acute alcoholic pancreatitis. Am J Gastroenterol 96 (2001) 1777-1781
2. Batoni G., Maisetta G., Esin S., and Campa M. Human beta defensin-3: a promising antimicrobial peptide. Mini Rev Med Chem 6 (2006) 1063-1073
3. Boniotto M., Antcheva N., Zelezetsky I., Tossi A., Palumbo V., Verga Falzacappa M.V., et al. A study of host defense peptide β-defensin 3 in primates. Biochem J 374 (2003) 707-714
4. Bowdish D.M.E., Davidson D.J., and Hancock R.E.W. A re-evaluation of the role of host defense peptides in mammalian immunity. Curr Protein Pept Sci 6 (2005) 35-51
5. Conlon J.M., Al-Ghaferi N., Abraham B., and Leprince J. Strategies for transformation of naturally-occurring amphibians antimicrobial peptides into therapeutically valuable anti-infective agents. Methods 42 (2007) 349-357
6. Dhople V., Krukemeyer A., and Ramamoorthy A. The human beta defensin 3, an antibacterial peptide with multiple biological functions. Biochem Biophys Acta 1758 (2006) 1499-1512
7. Felgentreff K., Beisswenger C., Griese M., Gulder T., Bringmann G., and Bals R. The antimicrobial peptide cathelicidin interacts with airway mucus. Peptides 27 (2006) 3100-3106
8. Harder J., Bartels J., Christophers E., and Schroder J.M. Isolation and characterization of human β-defensin 3, a novel human inducible peptide antibiotic. J Biol Chem 23 (2001) 5707-5713
9. Krauss D., and Peschel A. Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr Top Microbial Immunol 306 (2006) 231-250
10. Maisetta G., Batoni G., Esin S., Raco G., Bottai D., Favilli F., et al. Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human β-defensin 3 in biological fluids. Antimicrob Agents Chemother 49 (2005) 1245-1248
11. Maisetta G., Batoni G., Esin S., Florio W., Bottai D., Favilli F., et al. In vitro bactericidal activity of human β-defensin 3 against multidrug-resistant nosocomial strains. Antimicrob Agents Chemother 50 (2006) 806-809
12. Marr A.K., Gooderham W., and Hancock R.E.W. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharm 6 (2006) 468-472
13. Midorikawa K., Ouhara K., Komatsuzawa H., Kawai T., Yamada S., Fujiwara T., et al. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun 71 (2003) 3730-3739
14. Mookherjee N., and Hancock R.E.W. Cationic host defence peptides: innate immunity regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 64 (2007) 922-933
15. Niyonsaba F., Nagaoka I., and Ogawa H. Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit Rev Immunol 26 (2006) 545-576
16. Pazgier M., Hoover D.M., Yang D., Lu W., and Lubkowski J. Human β-defensins. Cell Mol Life Res 63 (2006) 1294-1313
17. Raimondo D., Andreotti G., Saint N., Amodeo P., Renzone G., Sanseverino M., et al. A folding-dependent mechanism of antimicrobial peptide resistance to degradation unveiled by solution structure of distinctin. PNAS 102 (2005) 6309-6314
18. Rice L.B. Do we really need new anti-infective drugs?. Curr Opin Pharmacol 3 (2003) 459-463
19. Sahl H.G., Pag U., Bonnes S., Wagner S., Antcheva N., and Tossi A. Mammalian defensins: structures and mechanism of antibiotic activity. J Leukoc Biol 77 (2005) 476-575
20. Shagger H., and von Jagow G. Tricine-sodium dodecyl sulfate-polyacrilamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166 (1987) 368-379
21. Svenson J., Brandsal B.O., Stensen W., and Svendsen J. Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect. J Med Chem 50 (2007) 3334-3339
22. Taggart C.C., Green C.M., Smith S.G., Levine R.L., McCray Jr. P.B., O'Neill S., et al. Inactivation of human beta-defensin 2 and 3 by elastolytic cathepsins. J Immunol 170 (2003) 931-937
23. Yadava P., Zhang C., Sun J., and Hughes J.A. Antimicrobial activities of human β-defensins against Bacillus species. Int J Antimicrob Agents 28 (2006) 132-137
24. Yeaman M.R., and Yount N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharm Rev 55 (2003) 27-55
25. Yu Q., Lehrer R.I., and Tam J.P. Engineered salt-insensitive alpha-defensins with end-to-end circularized structures. J Biol Chem 275 (2000) 3943-3949